Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment
Arthur E Brawer Division of Rheumatology, Department of Medicine, Monmouth Medical Center, Long Branch, NJ, USA Objectives: The diagnostic diversity of polymyalgia rheumatica (PMR) can easily be obscured by the widespread use of corticosteroids (CSs) early in the disease course. This study observed...
Guardado en:
Autor principal: | Brawer AE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fac9e62500f2409f8a4bc8f1a16b277b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
por: Manzo C, et al.
Publicado: (2016) -
Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study
por: Ciro Manzo, et al.
Publicado: (2020) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon E, et al.
Publicado: (2019) -
Polymyalgia rheumatica following infective triggersor vaccinations: a different subset of disease?
por: Paolo Falsetti, et al.
Publicado: (2020) -
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Ciro Manzo, et al.
Publicado: (2021)